Santen Pharmaceutical First-Half Revenue Rises 3.9% to ¥143.289 Billion

Basic earnings per share was ¥48.05 for the six months ended Sept. 30, 2026. Santen kept its fiscal 2027 revenue and operating profit forecasts unchanged.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.